mBio · 2020 · 13 citations · 50 references
MedicineImmunologyOphthalmologyImmunopathologyInflammationOcular ImmunologyCorneal DiseaseCorneal ImmunologyCorneal PathologyImmunopathology Of The EyeOcular InflammationViral Eye InfectionsCorneal MicrobiologyImmune-mediated Corneal InflammationOcular Herpes Simplex Virus InfectionOcular Viral Immune ResponsePersistent Infection-driven InflammationTh1 Immune ResponseViral Entry ReceptorsViral Therapeutic Targets
Herpes simplex virus 1 (HSV-1), a ubiquitous human pathogen, is capable of causing a progressive inflammatory ocular disease called herpes stromal keratitis (HSK). HSV-1 ocular infection leads to persistent inflammation in the cornea resulting in outcomes ranging from significant visual impairment to complete blindness. Our previous work showed that herpesvirus entry mediator (HVEM) promotes the symptoms of HSK independently of viral entry and that HVEM expression on CD45 + cells correlates with increased infiltration of leukocytes into the cornea during the chronic inflammatory phase of the disease. Here, we elucidated the role of HVEM in the pathogenic Th1 response following ocular HSV-1 infection and the contribution of HVEM binding partners in HSK pathogenesis. Investigating the molecular mechanisms of HVEM in promoting corneal inflammation following HSV-1 infection improves our understanding of potential therapeutic targets for HSK.
50
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Norihiko Watanabe, Maya Gavrieli, John R. Šedý et al. · Nature Immunology · 2003 · 872 citations
Life Sciences, Immunology, Oncology +12